… imDCs were generated from HLA-A2 positive peripheral blood mononuclear cells (PBMC) …
cytokine targets the human glioma cells to the CTLs we generated with the modified human …

… on NK cells and T cells provide attractive targets for the … natural killer-resistant fresh
solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes …

… are activated in target cells after incubation with aNK cell-derived EVs… Peripheral blood
mononuclear cells (PBMC) were isolated by … human cytotoxic T lymphocytes and NK cells secrete …

… resident lymphocytes, including T cells and NK cells,… target cells compared with NK cells in
peripheral blood (Fig 2, C), indicating that the former were impaired both in natural cytotoxicity …

… Studies focused on in vitro genotoxicity of other polyphenol constituents present in A. unedo
… To establish the levels of DNA damage in treated lymphocytes, we focused on two comet …

… studies have shown peripheral blood natural cytotoxicity to be … that aimed to restore
intratumoural NK cell-mediated cytotoxicity … It should be noted that the lack of tumour lymphocyte …

… target tissues and cells of the host organism, pathogenic bacteria behave differently. Between
them, toxin production creates an efficient way to modify specific functions of target cells. …

… studies have shown that targeting Natural Killer cells, as major … Peripheral blood Natural
Killer cells can be expanded and … of cytotoxicity of Natural killer cells and CD8 + T lymphocytes …

… sources each possess advantages and disadvantages for use in cellular therapy targeting
cancer (30). Peripheral blood NK (PB-NK) cells must be collected from a donor by apheresis …

… drug targeting in vivo include natural killer (NK) cells. These … of total peripheral blood
mononuclear cells (PBMCs) in humans … ) are also expressed by cytotoxic T lymphocytes, and mAb …